The Multiomics Blueprint: How a 116-Year-Old Redefines Human Aging and Resilience

What the world’s oldest known individual reveals about aging, resilience, and the limits of human life

By Ana Stankovic, PhD

Based on Santos-Pujol et al., “The Multiomics Blueprint of the Individual with the Most Extreme Lifespan,”

Cell Reports Medicine, October 2025.

A 116-Year-Old Case That Rewrites Our Understanding of Aging

The Cell Reports Medicine study by Santos-Pujol et al. (2025) presents the most detailed biological portrait ever captured of a supercentenarian — a 116-year-old woman from Catalonia. Using an integrated multiomics approach, the team profiled her genome, epigenome, proteome, metabolome, and microbiome to ask a deceptively simple question:

How does someone live more than a century without major disease?

Their answer reshapes how we think about aging itself.

Despite classical hallmarks of aging — telomere shortening, clonal hematopoiesis, and immune remodeling — this individual maintained robust metabolism, genomic stability, and an anti-inflammatory profile. Her biology shows that aging and disease, though related, are not the same process.

Decoupling Aging from Disease

Aging has long been seen as the direct driver of chronic disease. But the last decade of geroscience has challenged that idea. The updated Hallmarks of Aging framework (Lopez-Otín et al., 2023) and longitudinal proteomic studies (Johnson et al., 2023) suggest that aging is not merely damage accumulation — it’s a progressive loss of network resilience.

The Catalonian supercentenarian provides a striking proof of that concept.

Her body carried typical molecular “wear and tear,” yet her cellular systems remained coherently regulated — metabolic networks, immune control, and microbiota composition all stayed synchronized.

In other words, she aged, but she did not disintegrate.

That distinction — between aging and dysregulation — is the essence of what modern biology calls resilient aging.

The Biology of Resilience

What defined her resilience?

Several features converged:

• Low inflammation, indicated by extraordinarily low levels of GlycA and GlycB;
• High mitochondrial efficiency and oxidative stress resistance;
• Stable methylation at repetitive elements (LINE-1, ALU), preserving genomic integrity; and
• A youthful gut microbiome, dominated by Bifidobacterium and depleted of pro-inflammatory species.

Together, these traits depict a system that remained coordinated and self-repairing despite chronological aging — much like a well-tuned network that can absorb shocks without collapse.

This resonates with the idea proposed by Barabási and colleagues (2019): in complex systems, health equals network stability, and disease arises when those stabilizing connections fail.

Why This Matters for Aging Research

The study’s broader implication is philosophical as much as biological: it shifts our focus from fighting aging to understanding resilience.

Instead of targeting single “aging pathways,” researchers may need to focus on maintaining systemic coherence — the dynamic equilibrium among metabolism, immunity, epigenetics, and the microbiome.

This approach aligns with emerging multiomics work (Ahadi et al., 2020; Franceschi et al., 2022), which defines distinct “ageotypes” and epigenetic signatures of longevity.

M116’s biology shows that the potential for healthy extreme longevity lies not in escaping molecular aging, but in managing its consequences through coordinated repair and adaptation.

Redefining the Limits of Aging

The M116 case reframes the goal of geroscience. Rather than preventing aging itself, the focus shifts to preserving network stability—maintaining synchrony across metabolic, immune, and genomic systems.

As Barabási’s network medicine framework suggests, resilience emerges when redundancy and feedback within biological systems compensate for local failures.

Santos-Pujol et al. provide a human exemplar of this principle: a life that demonstrates not the absence of aging, but the presence of adaptive equilibrium.

Conclusion: Resilience, Not Immortality

The multiomics blueprint of M116 suggests that extreme longevity is achievable through systemic harmony, not the absence of molecular aging.

Her biology offers a profound lesson for translational geroscience: aging can proceed without disease when the body’s regulatory networks remain coherent.

In that sense, the future of aging research lies not in extending lifespan, but in decoding and sustaining the resilient complexity that defines a life extraordinarily well-lived.

References

1. Santos-Pujol, C. et al. The Multiomics Blueprint of the Individual with the Most Extreme Lifespan. Cell Reports Medicine 6, 102368 (2025).
2. Lopez-Otín, C. et al. The Hallmarks of Aging Revisited. Cell 186, 22–55 (2023).
3. Johnson, S.C. et al. Proteomic aging trajectories and inflammation predict health span. Nat Aging 3, 241–256 (2023).
4. Franceschi, C. et al. The Epigenetic Landscape of Longevity. Science 376, eabl7374 (2022).
5. Ahadi, S. et al. Personal aging markers and ageotypes revealed by deep longitudinal profiling. Nat Med 26, 83–90 (2020).
6. Barabási, A.-L. Network Medicine: A Network-Based Approach to Human Disease. Nat Rev Genet 20, 56–68 (2019).